entertainment -WSS

entertainment

author：leisure time 2025-09-06 03:26:12 - browse：65773

One Medical and Amazon Care apps displayed on a phone. -- health tech coverage from STAT. — Adobe

The graveyard is littered with Amazon’s bets in health care: wearables, Care, the ill-fated Haven. Out of their ashes, a new health strategy has emerged at the tech goliath. And while its leaders insist that Amazon has no grand plan for health care, a flurry of moves in the last year offer a glimpse into its ambitions at a time when they seem more cohesive than ever.

“We have learned a lot in the years that we’ve been dabbling in health care,” said Sunita Mishra, chief medical officer for Amazon Health Services. “And it’s now made us more confident that we’re on the right track.”

STAT spoke to four of Amazon’s chief medical officers about the company’s recent plays and how they fit into the company’s health care goals. Last November, it launched Amazon Clinic, a marketplace for virtual-only appointments for straightforward medical needs like pink eye, UTIs, and birth control. Two months later, its Amazon Pharmacy business launched RxPass, a $5 generic medication discount program, setting it up as a Walmart rival. And in February, it closed the acquisition of hybrid primary care company One Medical in a deal valued at $3.9 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Idaho college killings prosecutors challenge defense's grand jury claims

WSS

Surge in Apellis stock fueled by confidence in safety of its eye drug

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

'Make People Better': The CRISPR babies story you probably don't know

Ethical issues complicate the benefits of medical crowdfunding

Weighted lottery helped low

Humana sues Biden admin over Medicare Advantage audit rule

focus

entertainment

focus

Jerome Adams on the need for new antivirals for Covid

Snackable artificial intelligence, expert AI, and the pharma industry

Virginia high school admissions case could be legal follow

Judge sides with young activists in first

Wildfire smoke exposes gaps in outdoor worker protections

Be careful with at

Hepatitis C has a cure — but many Americans still lack access to it

Why Novartis is changing the name of its research labs

As demand for Covid shots wanes, Moderna seeks its next success

Patients, digital health players weigh in on FTC's data privacy plan

focus

Timeline: How the deadly wildfires took over Maui day by day

YouTube cracks down on misinformation on cancer treatment

Dozens dead from Maui wildfires: What we know about the victims

Biogen’s boardroom scandal saddles CEO with first crisis

'Make People Better': The CRISPR babies story you probably don't know

Novo Nordisk touts Wegovy study, but still struggling with supply

leisure time

leisure time

hotspot

hotspot